These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20452513)

  • 1. Procalcitonin in intensive care units: the PRORATA trial.
    Tarnow-Mordi W; Gebski V
    Lancet; 2010 May; 375(9726):1605; author reply 1606-7. PubMed ID: 20452513
    [No Abstract]   [Full Text] [Related]  

  • 2. Procalcitonin in intensive care units: the PRORATA trial.
    Mokart D; Leone M
    Lancet; 2010 May; 375(9726):1605; author reply 1606-7. PubMed ID: 20452515
    [No Abstract]   [Full Text] [Related]  

  • 3. Procalcitonin in intensive care units: the PRORATA trial.
    Gibot S
    Lancet; 2010 May; 375(9726):1605-6; author reply 1606-7. PubMed ID: 20452514
    [No Abstract]   [Full Text] [Related]  

  • 4. Procalcitonin in intensive care units: the PRORATA trial.
    Landman GW; Kleefstra N
    Lancet; 2010 May; 375(9726):1606; author reply 1606-7. PubMed ID: 20452516
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
    Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
    Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical biomarker procalcitonin (PCT) and its effect on antibiotic usage.
    Kappes J
    S D Med; 2010 May; 63(5):178-9. PubMed ID: 20462063
    [No Abstract]   [Full Text] [Related]  

  • 7. [Procalcitonin as a biomarker in infections].
    Christ-Crain M
    Praxis (Bern 1994); 2007 Jun; 96(25-26):1017-21. PubMed ID: 17639964
    [No Abstract]   [Full Text] [Related]  

  • 8. Procalcitonin-guided antibiotic treatment in heart failure.
    Sandek A; Springer J; Habedank D; Brunkhorst F; Anker SD
    Lancet; 2004 May; 363(9420):1555; author reply 1555-6. PubMed ID: 15135615
    [No Abstract]   [Full Text] [Related]  

  • 9. [Procalcitonin - a marker for managing antibiotic therapies?].
    Krawtchenko N; Franzen D; Müller B
    Praxis (Bern 1994); 2014 Feb; 103(4):187-93; quiz 194-5. PubMed ID: 24518234
    [No Abstract]   [Full Text] [Related]  

  • 10. Procalcitonin-guided antibiotic use in acute respiratory tract infections.
    Bollu M; Marte-Grau AC; Bobba RK
    Arch Intern Med; 2009 Apr; 169(7):716. PubMed ID: 19365003
    [No Abstract]   [Full Text] [Related]  

  • 11. Will procalcitonin reduce antibiotic use in intensive care?
    Kollef MH
    Lancet; 2010 Feb; 375(9713):435-6. PubMed ID: 20097416
    [No Abstract]   [Full Text] [Related]  

  • 12. [A Cochrane meta-analysis regarding procalcitonin is in accordance with international goals for the use of antibiotics].
    Berg PL; Lindhardt BO
    Ugeskr Laeger; 2013 Dec; 175(50):3093-6. PubMed ID: 24629531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there.
    Martinez FJ; Curtis JL
    Chest; 2007 Jan; 131(1):1-2. PubMed ID: 17218546
    [No Abstract]   [Full Text] [Related]  

  • 14. Host response biomarkers in sepsis: the role of procalcitonin.
    Vincent JL; Van Nuffelen M; Lelubre C
    Methods Mol Biol; 2015; 1237():213-24. PubMed ID: 25319789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Procalcitonin: a reliable marker for the diagnosis and monitoring of the course of bacterial infection].
    Holub M; Rozsypal H; Chalupa P
    Klin Mikrobiol Infekc Lek; 2008 Dec; 14(6):201-8. PubMed ID: 19214953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin-guided antibiotic use in primary care: the ultimate proof still ahead.
    Damoiseaux RA
    Arch Intern Med; 2009 Apr; 169(7):717-8. PubMed ID: 19365004
    [No Abstract]   [Full Text] [Related]  

  • 17. [Utility of procalcitonin for the diagnosis and the follow-up of infections in febrile neutropenic patients].
    Robinson JO; Calandra T; Marchetti O
    Rev Med Suisse; 2005 Mar; 1(13):878-82, 885-6. PubMed ID: 15895930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms.
    Schuetz P; Chiappa V; Briel M; Greenwald JL
    Arch Intern Med; 2011 Aug; 171(15):1322-31. PubMed ID: 21824946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.
    Jensen JU; Hein L; Lundgren B; Bestle MH; Mohr TT; Andersen MH; Thornberg KJ; Løken J; Steensen M; Fox Z; Tousi H; Søe-Jensen P; Lauritsen AØ; Strange D; Petersen PL; Reiter N; Hestad S; Thormar K; Fjeldborg P; Larsen KM; Drenck NE; Ostergaard C; Kjær J; Grarup J; Lundgren JD;
    Crit Care Med; 2011 Sep; 39(9):2048-58. PubMed ID: 21572328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can procalcitonin levels guide antibiotic therapy in bacterial infections and reduce antibiotic overconsumption without having a negative effect on clinical outcomes?
    Sandifer JP; Jones AE
    Ann Emerg Med; 2012 Sep; 60(3):370-1. PubMed ID: 22305332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.